{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:28:51Z","timestamp":1772231331001,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cytokinetics, Incorporated"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Obstructive hypertrophic cardiomyopathy (oHCM) has been studied primarily in comprehensive centers of excellence. Broadening the understanding of patients with oHCM in the general population may improve identification and treatment in other settings. This retrospective cohort study identified adults with oHCM from a large electronic medical record database comprising data from 39 integrated delivery networks (IBM Explorys; observational period: January 2009\u2013July 2019). Clinical characteristics, healthcare resource utilization (HCRU), and outcomes were reported. Of 8791 patients, 53.0% were female and the mean index age was 61.8 years. Cardiovascular drugs prescribed included beta-blockers (80.5%), calcium channel blockers (46.0%), and disopyramide (2.4%). Over time, heart failure, atrial fibrillation, and ventricular arrhythmias increased. Surgical procedures included septal myectomy (22.0%), alcohol septal ablation (0.6%), and heart transplantation (0.3%). Implantable cardioverter defibrillators were present in 11.2% of patients. After initial septal reduction therapy (SRT), HCRU increased and 550 patients (27.7%) required a reintervention. Of the overall group, 2.7% experienced sudden cardiac arrest by end of study. In conclusion, this cohort of patients with oHCM had guideline-recommended drug therapy and procedures. Despite this, heart failure, atrial fibrillation, and ventricular arrhythmias increased, and more than a quarter of patients undergoing SRT required reintervention. These unresolved issues emphasize the unmet need for new, effective therapies for patients with oHCM.<\/jats:p>","DOI":"10.3390\/jcm11133898","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T11:15:05Z","timestamp":1656933305000},"page":"3898","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States"],"prefix":"10.3390","volume":"11","author":[{"given":"Michael","family":"Butzner","sequence":"first","affiliation":[{"name":"Cytokinetics, Incorporated, Health Economics and Outcomes Research, 350 Oyster Point Blvd, South San Francisco, CA 94080, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Rowin","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, 860 Washington St Building, Boston, MA 02111, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Yakubu","sequence":"additional","affiliation":[{"name":"Genesis Research, 5 Marine View Plaza, Hoboken, NJ 07030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josiah","family":"Seale","sequence":"additional","affiliation":[{"name":"Genesis Research, 5 Marine View Plaza, Hoboken, NJ 07030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Robertson","sequence":"additional","affiliation":[{"name":"Cytokinetics, Incorporated, Clinical Research, 350 Oyster Point Blvd, South San Francisco, CA 94080, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Sarocco","sequence":"additional","affiliation":[{"name":"Cytokinetics, Incorporated, Health Economics and Outcomes Research, 350 Oyster Point Blvd, South San Francisco, CA 94080, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center and Research Institute, Division of Cardiology, Tufts Medical Center, 860 Washington St Building, Boston, MA 02111, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2021.11.021","article-title":"Management of hypertrophic cardiomyopathy: JACC state-of-the-art review","volume":"79","author":"Maron","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lu, D.Y., Pozios, I., Haileselassie, B., Ventoulis, I., Liu, H., Sorensen, L.L., Canepa, M., Phillip, S., Abraham, M.R., and Abraham, T.P. (2018). Clinical outcomes in patients with nonobstructive, labile, and obstructive hypertrophic cardiomyopathy. J. Am. Heart Assoc., 7.","DOI":"10.1161\/JAHA.117.006657"},{"key":"ref_3","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.112.000849","article-title":"Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction","volume":"128","author":"Desai","year":"2013","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: Present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.21037\/acs.2017.07.07","article-title":"Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: The Tufts experience","volume":"6","author":"Rastegar","year":"2017","journal-title":"Ann. Cardiothorac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.amjcard.2020.01.040","article-title":"Hypertrophic cardiomyopathy in \u201creal-world\u201d community cardiology practice","volume":"125","author":"Rowin","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0735-1097(02)03004-8","article-title":"Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration","volume":"41","author":"Kofflard","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","article-title":"Clinical course of hypertrophic cardiomyopathy in a regional United States cohort","volume":"281","author":"Maron","year":"1999","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.amjcard.2009.12.066","article-title":"Prevalence and clinical outcomes of incidentally diagnosed hypertrophic cardiomyopathy","volume":"105","author":"Efthimiadis","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12265-009-9135-4","article-title":"Looking for hypertrophic cardiomyopathy in the community: Why is it important?","volume":"2","author":"Nistri","year":"2009","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/hrt.50.6.530","article-title":"Hypertrophic cardiomyopathy: A common disease with a good prognosis. Five year experience of a district general hospital","volume":"50","author":"Shapiro","year":"1983","journal-title":"Br. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1532-5415.1979.tb01720.x","article-title":"Idiopathic hypertrophic subaortic stenosis as observed in a large community hospital: Relation to age and history of hypertension","volume":"27","author":"Petrin","year":"1979","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_17","first-page":"179","article-title":"The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy","volume":"35","author":"Shah","year":"1974","journal-title":"Circ. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0002-9149(93)91111-T","article-title":"Prognosis in hypertrophic cardiomyopathy observed in a large clinic population","volume":"72","author":"Kofflard","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","article-title":"Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population","volume":"102","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9149(94)90337-9","article-title":"Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study","volume":"73","author":"Maron","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"ref_21","unstructured":"The R Core Team (2022, May 12). R: A Language and Environment for Statistical Computing, Reference Index, R Foundation for Statistical Computing. Available online: https:\/\/softlibre.unizar.es\/manuales\/aplicaciones\/r\/fullrefman.pdf."},{"key":"ref_22","unstructured":"Microsoft Corporation (2022, April 01). Microsoft Excel. Available online: https:\/\/office.microsoft.com\/excel."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.amjcard.2016.02.044","article-title":"Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States","volume":"117","author":"Maron","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40119-022-00257-7","article-title":"Treatment changes, healthcare resource utilization, and costs among patients with symptomatic obstructive hypertrophic cardiomyopathy: A claims database study","volume":"11","author":"Owens","year":"2022","journal-title":"Cardiol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/13696998.2021.1978242","article-title":"Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States","volume":"24","author":"Jain","year":"2021","journal-title":"J. Med. Econ."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2022.03.023","article-title":"Characteristics of patients with obstructive hypertrophic cardiomyopathy in real-world community-based cardiovascular practices","volume":"174","author":"Butzner","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Butzner, M., Leslie, D., Cuffee, Y., Hollenbeak, C.S., Sciamanna, C., and Abraham, T.P. (2022). Sex differences in clinical outcomes for obstructive hypertrophic cardiomyopathy in the USA: A retrospective observational study of administrative claims data. BMJ Open, 12.","DOI":"10.1136\/bmjopen-2021-058151"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Rowin, E.J., Maron, M.S., Wells, S., Patel, P.P., Koethe, B.C., and Maron, B.J. (2019). Impact of sex on clinical course and survival in the contemporary treatment era for hypertrophic cardiomyopathy. J. Am. Heart Assoc., 8.","DOI":"10.1161\/JAHA.119.012041"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jamacardio.2019.0084","article-title":"Survival differences in women and men after septal myectomy for obstructive hypertrophic cardiomyopathy","volume":"4","author":"Meghji","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jchf.2017.09.011","article-title":"Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2018","journal-title":"JACC Heart Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jchf.2015.06.011","article-title":"A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy","volume":"3","author":"Liebregts","year":"2015","journal-title":"JACC Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/CIRCRESAHA.116.309348","article-title":"Hypertrophic obstructive cardiomyopathy: Surgical myectomy and septal ablation","volume":"121","author":"Nishimura","year":"2017","journal-title":"Circ. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/01.CIR.0000162460.36735.71","article-title":"Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy","volume":"111","author":"Woo","year":"2005","journal-title":"Circulation"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/13\/3898\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:42:42Z","timestamp":1760139762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/13\/3898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":33,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jcm11133898"],"URL":"https:\/\/doi.org\/10.3390\/jcm11133898","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]}}}